01409nas a2200157   4500000000100000008004100001100001400042700001200056700001400068700001300082245016900095856006900264490000600333024001600339520089600355       2020                            d1 aNicolas A1 aLAPO RA1 aAmadou CF1 aAhoyo TA00aExploration Of Renal Function In Leprosy Patients Under Treatment And Those Who Have Undergone Anti-Leprosy Treatment At The OUIDAH Leprosy Treatment Center (BENIN)  uhttp://www.jmhsci.org/wp-content/uploads/2020/11/BJMHS450192.pdf0 v2  aBJMHS4501923 aAim: The objective of this study is to evaluate the
effect of taking anti-leprosy drugs in leprosy patients
under treatment and at the end of treatment.
Materials and Methods: In order to achieve this,
we collected eighty (80) leprosy patients in whom we
measured urea and creatinine. We also determined
the creatinine clearance.
Results: The results obtained show an increase in
urea and creatinine concentrations in subjects with
more than four years of treatment compared to those
with between six months and four years of treatment.
A significant difference between these two types of
patients is obtained with the average creatinine
concentrations.
Conclusion: This shows that the duration of
treatment with anti-leprosy drugs has an effect on the
fundamental parameter of renal exploration,
creatinine, but also on urea, which is why there is a
risk of renal failure.